Search Results

There are 11341 results for: content related to: Tumor microvasculature with endothelial fenestrations in VHL null clear cell renal cell carcinomas as a potent target of anti-angiogenic therapy

  1. You have full text access to this OnlineOpen article
    Combined mutation of Vhl and Trp53 causes renal cysts and tumours in mice

    EMBO Molecular Medicine

    Volume 5, Issue 6, June 2013, Pages: 949–964, Joachim Albers, Michal Rajski, Désirée Schönenberger, Sabine Harlander, Peter Schraml, Adriana von Teichman, Strahil Georgiev, Peter J. Wild, Holger Moch, Wilhelm Krek and Ian J. Frew

    Version of Record online : 22 APR 2013, DOI: 10.1002/emmm.201202231

  2. You have free access to this content
    Hypoxia-inducible transcription factor 2α promotes steatohepatitis through augmenting lipid accumulation, inflammation, and fibrosis


    Volume 54, Issue 2, August 2011, Pages: 472–483, Aijuan Qu, Matthew Taylor, Xiang Xue, Tsutomu Matsubara, Daniel Metzger, Pierre Chambon, Frank J. Gonzalez and Yatrik M. Shah

    Version of Record online : 26 JUN 2011, DOI: 10.1002/hep.24400

  3. Regulation of E2F1 by the von Hippel–Lindau tumour suppressor protein predicts survival in renal cell cancer patients

    The Journal of Pathology

    Volume 231, Issue 1, September 2013, Pages: 117–129, Dorus A Mans, Joost S Vermaat, Bart G Weijts, Ellen van Rooijen, Jeroen van Reeuwijk, Karsten Boldt, Laura GM Daenen, Petra van der Groep, Benjamin D Rowland, Judith J Jans, Ronald Roepman, Emile E Voest, Paul J van Diest, Marianne C Verhaar, Alain de Bruin and Rachel H Giles

    Version of Record online : 6 AUG 2013, DOI: 10.1002/path.4219

  4. You have free access to this content
    Systemic VHL gene functions and the VHL disease

    FEBS Letters

    Volume 586, Issue 11, June 04, 2012, Pages: 1562–1569, Hannah L. Bader and Tien Hsu

    Version of Record online : 25 APR 2012, DOI: 10.1016/j.febslet.2012.04.032

  5. 1H NMR metabolomics analysis of renal cell carcinoma cells: Effect of VHL inactivation on metabolism

    International Journal of Cancer

    Volume 138, Issue 10, May 15 2016, Pages: 2439–2449, Miroslava Cuperlovic-Culf, Kevin Cormier, Mohamed Touaibia, Julie Reyjal, Sarah Robichaud, Mehdi Belbraouet and Sandra Turcotte

    Version of Record online : 29 JAN 2016, DOI: 10.1002/ijc.29947

  6. You have full text access to this OnlineOpen article
    Deletion of the von Hippel–Lindau gene causes sympathoadrenal cell death and impairs chemoreceptor-mediated adaptation to hypoxia

    EMBO Molecular Medicine

    Volume 6, Issue 12, December 2014, Pages: 1577–1592, David Macías, Mary Carmen Fernández-Agüera, Victoria Bonilla-Henao and José López-Barneo

    Version of Record online : 10 NOV 2014, DOI: 10.15252/emmm.201404153

  7. You have free access to this content
    Inactivation of Vhl in Osteochondral Progenitor Cells Causes High Bone Mass Phenotype and Protects Against Age-Related Bone Loss in Adult Mice

    Journal of Bone and Mineral Research

    Volume 29, Issue 4, April 2014, Pages: 820–829, Tujun Weng, Yangli Xie, Junlan Huang, Fengtao Luo, Lingxian Yi, Qifen He, Di Chen and Lin Chen

    Version of Record online : 19 MAR 2014, DOI: 10.1002/jbmr.2087

  8. Mosaicism in von Hippel–Lindau disease with severe renal manifestations

    Clinical Genetics

    Volume 84, Issue 6, December 2013, Pages: 581–584, P Wu, N Zhang, X Wang, T Li, X Ning, D Bu and K Gong

    Version of Record online : 5 FEB 2013, DOI: 10.1111/cge.12092

  9. Frequency of Von Hippel-Lindau germline mutations in classic and non-classic Von Hippel-Lindau disease identified by DNA sequencing, Southern blot analysis and multiplex ligation-dependent probe amplification

    Clinical Genetics

    Volume 72, Issue 2, August 2007, Pages: 122–129, FJ Hes, RB van der Luijt, ALW Janssen, RA Zewald, GJ de Jong, JW Lenders, TP Links, GPM Luyten, RH Sijmons, HJ Eussen, DJJ Halley, CJM Lips, PL Pearson, AMW van den Ouweland and DF Majoor-Krakauer

    Version of Record online : 4 JUL 2007, DOI: 10.1111/j.1399-0004.2007.00827.x

  10. Copy number profiling in von hippel-lindau disease renal cell carcinoma

    Genes, Chromosomes and Cancer

    Volume 50, Issue 7, July 2011, Pages: 479–488, Salwati Shuib, Wenbin Wei, Hariom Sur, Mark R. Morris, Dominic McMullan, Eleanor Rattenberry, Esther Meyer, Patrick H. Maxwell, Takeshi Kishida, Masahiro Yao, Farida Latif and Eamonn R. Maher

    Version of Record online : 31 MAR 2011, DOI: 10.1002/gcc.20865

  11. Clinical and pathological impact of VHL, PBRM1, BAP1, SETD2, KDM6A, and JARID1c in clear cell renal cell carcinoma

    Genes, Chromosomes and Cancer

    Volume 53, Issue 1, January 2014, Pages: 38–51, Lucy Gossage, Muhammed Murtaza, Andrew F. Slatter, Conrad P. Lichtenstein, Anne Warren, Beverley Haynes, Francesco Marass, Ian Roberts, Susan J. Shanahan, Andreas Claas, Andrew Dunham, Andrew P. May, Nitzan Rosenfeld, Tim Forshew and Tim Eisen

    Version of Record online : 29 OCT 2013, DOI: 10.1002/gcc.22116

  12. VHL mutations and their correlation with tumour cell proliferation, microvessel density, and patient prognosis in clear cell renal cell carcinoma

    The Journal of Pathology

    Volume 196, Issue 2, February 2002, Pages: 186–193, Peter Schraml, Kirsten Struckmann, Florian Hatz, Stefan Sonnet, Charlotte Kully, Thomas Gasser, Guido Sauter, Michael J. Mihatsch and Holger Moch

    Version of Record online : 18 DEC 2001, DOI: 10.1002/path.1034

  13. Genotype–phenotype correlations in VHL exon deletions

    American Journal of Medical Genetics Part A

    Volume 149A, Issue 10, October 2009, Pages: 2147–2151, Alisdair McNeill, Eleanor Rattenberry, Richard Barber, Pip Killick, Fiona MacDonald and Eamonn R. Maher

    Version of Record online : 16 SEP 2009, DOI: 10.1002/ajmg.a.33023

  14. You have free access to this content
    Von Hippel-Lindau gene alterations in sporadic benign and malignant pheochromocytomas

    International Journal of Cancer

    Volume 105, Issue 2, 10 June 2003, Pages: 190–195, Hilde Dannenberg, Ronald R. De Krijger, Erwin van der Harst, Mustaffa Abbou, Ynske IJzendoorn, Paul Komminoth and Winand N.M. Dinjens

    Version of Record online : 5 MAR 2003, DOI: 10.1002/ijc.11060

  15. You have free access to this content
    The multifaceted von Hippel–Lindau tumour suppressor protein

    FEBS Letters

    Volume 588, Issue 16, August 19, 2014, Pages: 2704–2711, Claire M. Robinson and Michael Ohh

    Version of Record online : 25 FEB 2014, DOI: 10.1016/j.febslet.2014.02.026

  16. You have free access to this content
    pVHL and PTEN tumour suppressor proteins cooperatively suppress kidney cyst formation

    The EMBO Journal

    Volume 27, Issue 12, June 18, 2008, Pages: 1747–1757, Ian J Frew, Claudio R Thoma, Strahil Georgiev, Andrea Minola, Manuela Hitz, Matteo Montani, Holger Moch and Wilhelm Krek

    Version of Record online : 22 MAY 2008, DOI: 10.1038/emboj.2008.96

  17. Clinical and molecular features of familial and sporadic cases of von Hippel-Lindau disease from Mexico

    Clinical & Experimental Ophthalmology

    Volume 38, Issue 3, April 2010, Pages: 277–283, Oscar F Chacon-Camacho, Fernando Rodriguez-Dennen, Alejandra Camacho-Molina, Astrid Rasmussen, Elisa Alonso-Vilatela and Juan C Zenteno

    Version of Record online : 22 FEB 2010, DOI: 10.1111/j.1442-9071.2010.02241.x

  18. Comprehensive mutational analysis of the VHL gene in sporadic renal cell carcinoma: Relationship to clinicopathological parameters

    Genes, Chromosomes and Cancer

    Volume 34, Issue 1, May 2002, Pages: 58–68, Keiichi Kondo, Masahiro Yao, Minoru Yoshida, Takeshi Kishida, Taro Shuin, Takeshi Miura, Masatoshi Moriyama, Kazuki Kobayashi, Naoki Sakai, Shigeki Kaneko, Satoshi Kawakami, Masaya Baba, Noboru Nakaigawa, Yoji Nagashima, Yukio Nakatani and Masahiko Hosaka

    Version of Record online : 7 FEB 2002, DOI: 10.1002/gcc.10054

  19. You have full text access to this Open Access content
    Sequencing of the Von Hippel-Lindau Gene in Canine Renal Carcinoma

    Journal of Veterinary Internal Medicine

    Volume 23, Issue 3, May/June 2009, Pages: 592–597, B. M. Pressler, L. E. Williams, J. A. Ramos-Vara and K. I. Anderson

    Version of Record online : 21 APR 2009, DOI: 10.1111/j.1939-1676.2009.0310.x

  20. E2F1 in renal cancer: Mr Hyde disguised as Dr Jekyll?

    The Journal of Pathology

    Volume 231, Issue 2, October 2013, Pages: 143–146, Weihua Tian, Fenggong Cui and Miguel A Esteban

    Version of Record online : 10 SEP 2013, DOI: 10.1002/path.4238